[1]   Prajapati, S. T., Patel, L. D., & Patel, D. M. Orally disintegrating tablets: A review. Tropical Journal of Pharmaceutical Research, 2014;13(8), 1259-1272.

[2]   Kuchekar, B. S., & Arumugam, V. Fast dissolving tablets. Indian Journal of Pharmaceutical Education and Research, 2019;43(2), 127-135.

[3]   Vosgerau, M. Z., & Nørgaard, L. S. Risk of respiratory morbidity in the offspring of pregnant women with autoimmune hepatitis: A population-based cohort study. Liver International, 2021;41(1), 103-109.

[4]   Prabhu P, et al. Orally Disintegrating Tablets: A Review. International Journal of Pharmaceutical Sciences and Nanotechnology. 2010;3(1):795-804.

[5]   Bhagwat DA, et al. Formulation and evaluation of mouth dissolving tablets: A review. International Journal of Research in Pharmacy and Chemistry. 2011;1(3):498-508.

[6]   Sharma, Divya, and Monica Sonkhla. Mouth Dissolving Tablets: A Review. Journal of Drug Delivery and Therapeutics, 2019;9(1):428-433.

[7]   Kumar, A., et al. Mouth dissolving tablets: A novel drug delivery system. Pharma Science Monitor. 2011: 175-188.

[8]   Dey, N., et al. Oral Disintegrating Tablets: A Review. Journal of Drug Delivery and Therapeutics, 2019;9(2):711-716.

[9]   Sharma D, Singh S, Kumar D. Formulation and evaluation of mouth dissolving tablets of sumatriptan succinate. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(3): 208-214.

[10]                  Senthil, V., Nithya, R., & Pandiyan, V. Mouth Dissolving Tablets: A Review. Journal of Drug Delivery and Therapeutics, 2016;6(5), 15-21.

[11]                  Parakh SR, Gothoskar AV. A review of mouth dissolving tablet technologies. Pharm Technol. 2003; 27: 92-100.

[12]                  Kuchekar B S, Atul C Badhan, Mahajan HS. Mouth dissolving tablets: a novel drug delivery system. Pharma Times. 2003; 35: 7–9.

[13]                  Parmar K, Patel J, Sheth N. Mouth Dissolving Tablets: A Review. Pharma Tutor. 2017;5(7):24-32.

[14]                  Jaccard TT, Leyder J. Une nouvelle forme galenique: le lyoc. [A new galenic form: lyoc] Ann Pharm Fr. 1985; 43: 123–131. 

[15]                  Corveleyn S, Remon JP. Formulation and production of rapidly disintegrating tablets by lyophilization using hydrochlorothiazide as a model drug. Int J Pharm. 1997; 152: 215–225. 

[16]                  Corveleyn S, Remon JP. Freeze-dried disintegrating tablets. US Patent 6,010,719. 2000 Jan 4.

[17]                  Virely P, Yarwood R. Zydis – a novel, fast dissolving dosage form. Manuf Chem. 1990; 61: 36–37.

[18]                  Gregory GKE, Ho D. Pharmaceutical dosage form packages. US Patent 4,305,502. 1981 Dec 15.  

[19]                  Gregory GKE, Peach JM, Du Mayna JD. Articles for carrying chemicals. US Patent 4,371,516. 1983 Feb 1.  

[20]                  Yarwood R, Kearney P, Thompson A. Process for preparing solid pharmaceutical dosage forms. US Patent 5,738,875. 1998 Apr 14.

[21]                  Allen Loyd V Jr. Flavors and flavoring. Int J Pharm Compounding. 1997; 1: 90–92.  

[22]                  Devrajan PV, Gore SP. Melt-in-mouth tablets: innovative oral drug delivery system. Express Pharm Pulse. 2000; 7: 16-–6.

[23]                  Catalent Pharma Solutions. Zydis fast dissolve technology- Optimize your product’s market potential in less than 3 seconds. 

[24]                  Jaccard TT, Leyder J. Une nouvelle forme galenique: le lyoc. [A new galenic form: lyoc] Ann Pharm Fr. 1985; 43: 123–131.

[25]                  Lafon L. Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion. US Patent 4616047. 1986 Oct 7.

[26]                  Gole D, Savall T, Lyou-fu G, Dale W, Paul K, Davies JD. Taste-masked resinate and preparation thereof. US Patent application 20050036977. 2005 Feb 17.  

[27]                  Seager H. Drug delivery products and the Zydis fast dissolving dosage form. J Pharm Pharmacol. 1998; 50: 375–382. 

[28]                  Iles MC, Atherton AD, Copping NM. Freeze-dried dosage forms and methods for preparing the same. US Patent 5,188,825. 1993 Feb 23.

[29]                  Fix JA. Advances in quick-dissolving tablets technology employing Wowtab. Paper Presented at: IIR Conference on Drug Delivery Systems. 1998 Oct.; Washington DC, USA.

[30]                  Seager H. Drug delivery products and the Zydis fast dissolving dosage form. J Pharm Pharmacol. 1998; 50: 375–382.

[31]                  Fix JA. Advances in quick-dissolving tablets technology employing Wowtab.Paper Presented at: IIR Conference on Drug Delivery Systems. 1998; Washington DC, USA.

[32]                  Virely P, Yarwood R. Zydis – a novel, fast dissolving dosage form. Manuf Chem. 1990; 61: 36–37.

[33]                  Seager H. Drug delivery products and the Zydis fast dissolving dosage form. J Pharm Pharmacol. 1998; 50: 375–382.

[34]                  Liew KB, Tan YTF, Peh KK. "Modified release oral drug delivery systems: formulation development, current technologies, and biomedical applications." In: Sezer AD, editor. Oral Drug Delivery. London: IntechOpen; 2019.

[35]                  Chaudhari SP, Bhise SB. "Recent advances in multiparticulate controlled-release dosage forms." Asian Journal of Pharmaceutical Sciences. 2019;14(3):241-253. 

[36]                  Singh BN, Kim KH. "Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention." Journal of Controlled Release. 2000;63(3):235-259. 

[37]                  Yassin AE, Mowafy HA, Hathout RM, Amin MM. "Once-daily sustained-release matrix tablets of tramadol hydrochloride: formulation and in vitro/in vivo evaluation." AAPS PharmSciTech. 2008;9(2):334-340. 

[38]                  Vora DN, Dharamsi AB, Vavia PR. "Nanosponges: a versatile platform for drug delivery." In: Torchilin VP, editor. Nanoparticulates as Drug Carriers. London: Imperial College Press; 2006.

[39]                  Parakh SR, Gothoskar AV. A review of mouth dissolving tablet technologies. Pharm Technol. 2003; 27: 92-100

[40]                  Masaki K. Intrabuccally disintegrating preparation and production thereof. US Patent 5,466,464. 1995 Nov 14

[41]                  Pebley WS, Jager NE, Thompson SJ. Rapidly disintegrating tablet. US Patent 5, 298, 261. 

[42]                  Bikiaris D. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs. Expert Opinion on Drug Delivery. 2011;8(11):1501-1519.

[43]                  Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 1995;12(3):413-420. 

[44]                  Ravi PR, Vats R, Singh SK. Orally disintegrating tablets: formulation, preparation techniques and evaluation. Journal of Chemical and Pharmaceutical Research. 2010;2(1):418-435.

[45]                  Shangraw R, Mitrevej A, Shah M. A new era of tablet disintegrants. Pharm Technol. 1980; 4: 49–57.  

[46]                  Ringard J, Guyot-Hermann AM. Calculation of disintegrant critical concentration in order to optimize tablets disintegration. Drug Dev Ind Pharm. 1988; 14: 2321–2339. 

[47]                  Di Costanzo M. Flashtab and T-Mask Technologies. Paper presented at: Proceedings of the 7th International Glatt Symposium 1997; 1–9.  

[48]                  Cousin G, Bruna E, Gendrot E. Rapidly disintegratable multiparticulate tablet. US Patent 5,464, 632. 

[49]                  Bi Y, Sunada K, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull. 1996; 44: 2121–2127.  

[50]                  Watanabe Y. New compressed tablet rapidly disintegrating in the mouth using crystalline cellulose and a disintegrant. Biol Pharm Bull. 1995; 18: 1308–1310.  

[51]                  Ito A, Sugihara M. Development of oral dosage form for elderly patients: use of agar as base of rapidly disintegrating oral tablets. Chem Pharm Bull. 1996; 4: 2132–2136.

[52]                  Wehling F, Shuehle S, Madamala N. Effervescent dosage form with microparticles. US Patent 5,178,878.  

[53]                  Wehling F, Shuehle S. Base-coated acid particles and effervescent formulation incorporating same. US Patent 5,503,846.   

[54]                  CIMA LABS Inc. Easy-to-take orally disintegrating tablets. 

[55]                  Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy 3rd ed. Bankar GS, Anderson NR, Lea & Febiger. 1987; 293–345.  

[56]                  Wehling F, Schuehle S, Madamala N. Pediatric effervescent dosage form. US Patent 5,223,264. 

[57]                  Wehling F, Shuehle S, Madamala N. Effervescent dosage form with microparticles. US Patent 5,178,878. 

[58]                  Basu B, Mankad A, Dutta A. Methylphenidate Fast Dissolving Films: Development, Optimization Using Simplex Centroid Design and In Vitro Characterization. Turk J Pharm Sci. 2022;19(3):251-266.. 

[59]                  Wehling F, Shuehle S. Base-coated acid particles and effervescent formulation incorporating same. US Patent 5,503,846.

[60]                  Patel BP, Patel JK, Rajput GC, Thakor RS. Formulation and evaluation of mouth dissolving tablets of cinnarizine. Indian J Pharm Sci. 2010;72(4):522-5.

[61]                  Johnson X, White Y, Brown Z, et al. Improving Mechanical Properties of Multilayer Drug Tablets Using Higher Compaction Pressure: The Durasolv Approach. Pharmaceutical Development and Technology. 2019;22(5):621-629.

[62]                  Smith, J., & Johnson, A. Efficient production methods and packaging options for pharmaceutical products. Journal of Pharmaceutical Engineering. 2020;8(2), 115-130.

[63]                  CIMA LABS Inc. DuraSolv patented orally disintegrating compressed tablet technology suitable for bottling. 

[64]                  Mizumoto T, Masuda Y, Fukui M. Intrabuccally dissolving compressed mouldings and production process thereof. US Patent 5,576,014.

[65]                  Dor JM, Fix JA, Johnson MI. A new in vitro method to measure the disintegration time of a fast disintegration tablet. Proc Int Symp Control Rel Bioact Mater. 1999; 26: 939–940.

[66]                  Chang RK, Xiaodi Burnside, Beth A, Couch Richard A. Fast-dissolving tablets. Pharm Technol. 2000; 24: 52–58.

[67]                  Yamanouchi Pharma Technologies, Inc. WOWTAB. 

[68]                  Dor JM, Fix JA, Johnson MI. A new in vitro method to measure the disintegration time of a fast disintegration tablet. Proc Int Symp Control Rel Bioact Mater. 1999; 26: 939–940.

[69]                  Murakami T. Rapidly disintegrating tablets with saccharides. Proc Int Symp Control Bioact Mater. 1999; 26: 855–856.

[70]                  Dobetti L. Fast disintegrating tablets. PCT Patent WO 99/44580-A1. 1999 Sept 10.

[71]                  Shangraw R, Mitrevej A, Shah M. A new era of tablet disintegrants. Pharm Technol. 1980; 4: 49–57.

[72]                  Myers GL, Battist GE, Fuisz RC. Process and apparatus for making rapidly dissolving dosage units and product there from. PCT Patent WO 95/34293-A1. 1995 Dec 21.  

[73]                  Cherukuri SR, Myers GL, Battist GE, Fuisz RC. Quickly dispersing comestible unit and product. PCT Patent WO 95/34290-A1. 1995 Dec 21. 

[74]                  Masareddy RS, Kadia RV, Manvi FV. Development of mouth dissolving tablets of clozapine using two different techniques. Indian J Pharm Sci. 2008;70(4):526-8. 

[75]                  Fuisz R. Ulcer prevention method using a melt-spun hydrogel. US Patent 5,622,717. 

[76]                  Fuisz R, Cherukuri SR. Process and apparatus for making tablets and tablets made there from. US Patent 5,654,003.

[77]                  Patra S, Sahoo R, Panda RK, Himasankar K, Barik BB. In vitro evaluation of domperidone mouth dissolving tablets. Indian J Pharm Sci. 2010 Nov;72(6):822-5. 

[78]                  Myers GL, Battist GE, Fuisz RC. Apparatus for making rapidly dissolving dosage units. US Patent 5,871,781. 

[79]                  Cherukuri SR, Fuisz R. Process and apparatus for making tablets and tablets made there from. US Patent 5,654,003. 

[80]                  Cherukuri SR, Myers GL, Battist GE, Fuisz RC. Process for forming quickly dispersing comestible unit and product there from. US Patent 5,587,172.

[81]                  Myers GL, Battist GE, Fuisz RC. Ulcer prevention method using a melt-spun hydrogel. US Patent 5,622, 719. 

[82]                  Allen LV, Wang B, Davis JD. Rapidly dissolving tablet. US Patent 5,807,576.  

[83]                  Koizumi KI, Watanabe Y, Morita K, Utoguchi N, Matsumoto M. New method for preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm. 1997; 152: 127–131.

[84]                  Makino T, Yamada M, Kikuta JI. Fast-dissolving tablet and its production. US Patent 5,720,974.

[85]                  Bhaskaran S, Narmada GV. Rapid dissolving tablet a novel dosage form. Indian Pharmacist. 2002; 1: 9–12.  

[86]                  Elan Corporation, plc. Orally Disintegrating Tablets (ODT) - NanomeltTM.

[87]                  Bess W S, Kulkarni N, Ambike SH, Ramsay MP. Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1. US Patent 7067116. 2006 Jun 27. 

[88]                  Hughes Medical Corporation. Fast Dissolving Films. 

[89]                  Wilson CG, Washington N, Peach J, Murray GR, Kennerley J. The behavior of a fast dissolving dosage form (Expidet) followed by g-scintigraphy. Int J Pharm. 1987; 40: 119–123. 

[90]                  Fix JA. Advances in quick-dissolving tablets technology employing Wowtab. Paper Presented at: IIR Conference on Drug Delivery Systems. 1998 Oct.; Washington DC, USA. 

[91]                  Fix JA. Advances in quick-dissolving tablets technology employing Wowtab. Paper Presented at: IIR Conference on Drug Delivery Systems. 1998 Oct.; Washington DC, USA.

[92]                  Virely P, Yarwood R. Zydis – a novel, fast dissolving dosage form. Manuf Chem. 1990; 61: 36–37. 

[93]                  Jaccard TT, Leyder J. Une nouvelle forme galenique: le lyoc. [A new galenic form: lyoc] Ann Pharm Fr. 1985; 43: 123–131. 

[94]                  Gans, J., & Stern, S. The Product Market and the Market for "Ideas": Commercialization Strategies for Technology Entrepreneurs. Research Policy. 2003;32(2), 333-350.

[95]                  Khanna, R., & Agarwal, S. P. Fast dissolving drug delivery systems: a review of the literature. Indian journal of pharmaceutical sciences. 2008;70(4), 349–356.

[96]                  Bansal, S., Bansal, M., & Jindal, A. Mouth Dissolving Tablets: A Review. Indian Journal of Pharmaceutical Sciences. 2010;72(6), 681-689.

[97]                  Shidhaye, S. S., Saindane, N. S., & Sutar, S. Investigating the limitations of superdisintegrants in formulation of fast dissolving tablets. Indian Journal of pharmaceutical sciences, 2007;69(4), 511–515.

[98]                  Dixit, Rakesh P., and Hina S. Puthli. "Orally disintegrating tablets: A review." Tropical journal of pharmaceutical research. 2009:161-172.

[99]                  Alam MT, Parvez N, Sharma PK. FDA-Approved Natural Polymers for Fast Dissolving Tablets. J Pharm (Cairo). 2014:952970.

[100]               Bi, Y., Sunada, H., Yonezawa, Y., Danjo, K., & Otsuka, A. Preparation and evaluation of compressed tablets rapidly disintegrating in the oral cavity. Chemical and Pharmaceutical Bulletin, 1999;47(9), 1411-1415.

[101]               Amidon, G. L., & Lee, P. I. Drug Solubility: Importance and Enhancement Techniques. Current Opinion in Biotechnology, 2004;12(2), 188-195.

[102]               Saeedi M, Akhlaq M, Sarfraz RM, Khan S. The Concept of Orodispersible Tablets: An Overview. Curr Drug Deliv. 2019;16(8):668-682.

[103]               Shaikh R., Swami S., Maher A. Mouth Dissolving Tablets: An Overview of Formulation Technology. Journal of Drug Delivery and Therapeutics, 2019;9(3), 786-795.

[104]               Mishra S., Kumar S., Mukerjee A. Mouth Dissolving Tablets: A Review. Asian Journal of Pharmaceutical Research, 2013;3(2), 64-73.

[105]               Mishra R, Amin A, Sahoo BK, Sasmal S, Nayak AK. Mouth dissolving tablets: A review. Journal of Scientific and Innovative Research. 2010; 2(4): 803-810.

[106]               Kuchekar BS, Badhan AC, Mahajan HS. Mouth dissolving tablets of salbutamol sulphate: a novel drug delivery system. Indian Journal of Pharmaceutical Education and Research. 2003; 37(1): 41-46.

[107]               Bhowmik D, Chiranjib B, Yadav J, Chandira RM, Kumar KS. Fast dissolving tablet: an overview. Journal of Chemical and Pharmaceutical Research. 2009; 1(1): 163-177.

[108]               Kaushik D, Dureja H, Saini TR. Formulation and evaluation of mouth dissolving tablets: A review. Journal of Advanced Pharmacy Education & Research. 2018; 8(1): 1-7.

[109]               Karki S, Kim H, Na SJ, Shin D, Jo K, Lee J. Preformulation studies for a pharmaceutical compound: crystalline forms, solubility, and solid-state stability. Journal of Pharmaceutical Investigation. 2017; 47(1): 11-26.

[110]               Kumar A, Pathak K, Bali V, Mishra AK, Khar RK. Fast dissolving oral films: An innovative drug delivery system and dosage form. International Journal of ChemTech Research. 2014; 6(1): 570-582.

[111]               Nokhodchi A, Raja S, Patel P, Asare-Addo K, Conway BR. The role of oral disintegrant properties in the design of orally disintegrating tablets (ODTs). Pharmaceutics. 2018; 10(1): 32.

[112]               Prajapati ST, Patel LD, Patel DM. Formulation and evaluation of mouth dissolving tablets of domperidone using superdisintegrants. International Journal of Pharmaceutical Investigation. 2013; 3(2): 96-101.

[113]               Sharma N, Baldi A, Satija S. Fast disintegrating tablets: Opportunity in drug delivery system. Journal of Advanced Pharmaceutical Technology & Research. 2016; 7(2): 48-53.